We are presenting our novel MTHFD1/2 inhibitor at the DDR inhibitor summit
We are presenting our data at the DDR inhibitor summit,
We are presenting our data at the DDR inhibitor summit,
We look forward to meeting you in person and sharing
Our team is happy and proud to have been voted
CEO Ana Slipicevic present the MTHFD2 program and one-carbon therapeutics
One-carbon therapeutics AB is granted 3,000,000 SEK from Sweden’s innovation agency
We are proud that the MTHFD2 inhibitors are now published
We are very pleased to announce that Dr Ana Slipicevic
Menu bar